查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1416338

一氧化氮吸入市场报告：2030 年趋势、预测与竞争分析

Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

吸入一氧化氮的趋势和预测

预计到 2030 年，全球吸入一氧化氮市场将达到 11 亿美元，2024 年至 2030 年复合年增长率为 5.1%。该市场的主要驱动因素是呼吸系统疾病和其他相关疾病的日益流行，以及持续的研发活动。全球吸入一氧化氮市场前景广阔，新生儿呼吸治疗、气喘和慢性阻塞性肺病、急性呼吸窘迫症候群、疟疾治疗和结核病治疗市场充满机会。

吸入一氧化氮市场洞察

Lucintel 预测，紧凑型可携式输送系统的引入将在预测期内实现更高的成长。这有利于在各种医疗保健应用中进行一氧化氮疗法。

在这个市场中，由于烟草消费量的增加，导致气喘和慢性阻塞性肺病的症状，预计气喘和慢性阻塞性肺病的成长最快。

由于慢性阻塞性肺病和气喘等疾病发病率急剧上升、人口老化加剧以及主要保险公司在该地区的存在，预计北美地区在预测期内将出现最高的增长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球吸入一氧化氮市场预计将达到 11 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球吸入一氧化氮市场预计将以5.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 此市场的主要驱动因素是呼吸道疾病和其他相关疾病的日益流行，以及持续的研发活动。

Q4.市场的主要细分市场是：

A4. 吸入一氧化氮市场的未来前景广阔，在新生儿呼吸治疗、气喘和慢性阻塞性肺病、急性呼吸窘迫症候群、疟疾治疗和结核病治疗市场上都有机会。

Q5.市场的主要企业是：

A5.主要的吸入一氧化氮公司如下。

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6.未来最大的细分市场是什么？

A6.Lucintel预测，由于紧凑型和可携式输送系统的引入，输送系统在预测期内将出现更高的增长。这有利于在各种医疗保健应用中进行一氧化氮疗法。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于慢性阻塞性肺病和气喘等疾病的发生率急剧上升、人口老化以及主要保险公司在该地区的存在，预计北美地区将在预测期内出现最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球吸入一氧化氮市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球吸入一氧化氮市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球吸入一氧化氮市场
    • 气体
    • 输送系统
  • 全球吸入一氧化氮市场（按应用）
    • 新生儿呼吸治疗
    • 气喘及慢性阻塞性肺病
    • 急性呼吸频率综合症
    • 疟疾治疗
    • 结核病治疗
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球吸入一氧化氮市场区域分布
  • 北美吸入一氧化氮市场
  • 欧洲吸入一氧化氮市场
  • 亚太地区吸入一氧化氮市场
  • 其他区域吸入一氧化氮市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球吸入一氧化氮市场成长机会
    • 全球吸入一氧化氮市场成长机会（按应用）
    • 按地区分類的全球吸入一氧化氮市场成长机会
  • 全球吸入一氧化氮市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球吸入一氧化氮市场产能扩张
    • 全球吸入一氧化氮市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure
简介目录

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

A more than 150-page report is developed to help in your business decisions.

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Gas
  • Delivery Systems

Inhaled Nitric Oxide Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Neonatal Respiratory Treatment
  • Asthma and COPD
  • Acute Respiratory Distress Syndrome
  • Malaria Treatment
  • Tuberculosis Treatment
  • Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Inhaled Nitric Oxide Market Insights

Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Within this market, asthma and COPD is expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.

North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the inhaled nitric oxide market size?

Answer: The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030.

Q2. What is the growth forecast for inhaled nitric oxide market?

Answer: The global inhaled nitric oxide market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the inhaled nitric oxide market?

Answer: The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

Q4. What are the major segments for inhaled nitric oxide market?

Answer: The future of the inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets.

Q5. Who are the key inhaled nitric oxide market companies?

Answer: Some of the key inhaled nitric oxide companies are as follows:

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6. Which inhaled nitric oxide market segment will be the largest in future?

Answer: Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Q7. In inhaled nitric oxide market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inhaled Nitric Oxide Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Inhaled Nitric Oxide Market by Product Type
    • 3.3.1: Gas
    • 3.3.2: Delivery Systems
  • 3.4: Global Inhaled Nitric Oxide Market by Application
    • 3.4.1: Neonatal Respiratory Treatment
    • 3.4.2: Asthma and COPD
    • 3.4.3: Acute Respiratory Distress Syndrome
    • 3.4.4: Malaria Treatment
    • 3.4.5: Tuberculosis Treatment
    • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Inhaled Nitric Oxide Market by Region
  • 4.2: North American Inhaled Nitric Oxide Market
    • 4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.3: European Inhaled Nitric Oxide Market
    • 4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.4: APAC Inhaled Nitric Oxide Market
    • 4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.5: ROW Inhaled Nitric Oxide Market
    • 4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
    • 6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
  • 6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Air Liquide Healthcare
  • 7.2: BOC Healthcare
  • 7.3: Matheson Tri-Gas
  • 7.4: Merck
  • 7.5: Mallinckrodt Pharmaceuticals
  • 7.6: Nu-Med Plus
  • 7.7: Perma Pure